Tag Archives: John Liddicoat M.D.

Medtronic announces U.S. commercial launch for its portfolio of Azure(TM) pacemakers with BlueSync(TM)technology

Azure(TM) with BlueSync(TM) Technology Improves Device Longevity  and Provides Automatic, Wireless Remote Patient Monitoring DUBLIN, 21-Nov-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers … Read the full press release

Medtronic presents results of new approach to implantable cardioverter defibrillator (ICD) therapy at CARDIOSTIM / EHRA EUROPACE 2016

Places ICD Leads Under Rib Cage, Outside Heart and Veins DUBLIN and NICE, FRANCE, 09-Jun-2016 — /EuropaWire/ — Medtronic plc (NSYE: MDT) today announced results from several feasibility studies evaluating a new approach to implantable cardioverter defibrillator (ICD) therapy at CARDIOSTIM … Read the full press release